Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
Taken together, long-term data from a pivotal sham-controlled trial and a single-arm study demonstrate Optilume BPH’s durable efficacy over at least 3 years. The Optilume® benign prostatic hyperplasia ...
Dr. Steven A. Kaplan presented positive 4-year and 12-month clinical outcomes during the American Urological Association's Annual Meeting "The positive data from the PINNACLE and EVEREST trials – ...
A postmarketing study showed that the Optilume BPH system improved the flow of urine while leaving sexual function unchanged in men with benign prostatic hyperplasia (BPH), researchers reported at the ...
Optilume BPH is expected to have a significant global impact in urology, offering a novel alternative treatment option for enlarged prostate "We are proud at University Urology Associates to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results